Kalaris Therapeutics, Inc.
KLRS
DELAYED 1 MONTH

8 insider filings · Latest: Jun 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 20, 2026May 22 11:47 PMSrinivas AkkarajuDirector, 10% Owner
Purchase
244,300$4.83$1.2M2,224,147(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 3, 2026Jun 4 8:38 PMJovan-Embiricos MoranaDirector
Grant/Award
9,000$4.729,000(D)

View →

Jun 3, 2026Jun 4 8:36 PMNapoleone FerraraDirector
Grant/Award
9,000$4.729,000(D)

View →

Jun 3, 2026Jun 4 8:28 PMDavid HallalDirector
Grant/Award
9,000$4.729,000(D)

View →

Jun 3, 2026Jun 4 8:25 PMSrinivas AkkarajuDirector
Grant/Award
9,000$4.729,000(D)

View →

Jun 3, 2026Jun 4 8:23 PMMichael DybbsDirector
Grant/Award
9,000$4.729,000(D)

View →

Jun 3, 2026Jun 4 8:22 PMAnthony P AdamisDirector
Grant/Award
9,000$4.729,000(D)

View →

Jun 3, 2026Jun 4 8:19 PMLeone D PattersonDirector
Grant/Award
9,000$4.729,000(D)

View →